CMR substances - European Commission
Skip to main content
An official website of the European UnionAn official EU website
Internal Market, Industry, Entrepreneurship and SMEs

EU cosmetics legislation contains provisions on the use of substances classified as carcinogenic, mutagenic, or toxic for reproduction (CMR substances) in cosmetic products. In general, the use of CMR substances is prohibited, apart from in exceptional cases.

EU rules for CMR substances

Article 15 of the Cosmetics Regulation 1223/2009 contains provisions on the use of CMR in cosmetic products. As a general principle, substances classified as CMR substances of category 1A, 1B, or 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 are banned for use in cosmetic products. Exceptions to this general rule are possible subject to the conditions laid down in Article 15 of the Cosmetics Regulation.

See the practical guidelines on the procedural steps that economic operators should consider.

EU guidance for the overall exposure assessment of CMR substances in cosmetic products

According to Regulation (EC) N° 1223/2009 on cosmetic products, the safety of substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR) should be assessed taking account of the exposure from all sources (cosmetics, chemicals, food, medicinal products) according to a comprehensive approach. The EU guidance for overall exposure assessment (19 kB) has been developed in consultation with the scientific committee on consumer safety (SCCS), the European Chemical Agency (ECHA), the European Medicine Agency (EMA) and the European Food Safety Authority (EFSA). It clarifies the respective roles of the industry, the Commission responsible Services, the SCCS and these European agencies for collecting, providing and analysing the exposure data.

CMR: related information

Stakeholders can also follow the discussions on harmonised classification and labelling of substances by following the links from the European Chemicals Agency listed below

 

Harmonised classifications of CMR substances and their prohibition under the Cosmetic Products Regulation (CPR)

ATP

(Adaptation to 

Technical Progress)

Amending Regulation to CLPCPR Omnibus ActAmending Regulation to CPRApplication date
(all previous ATPs)IRegulation (EU) 2019/83112 June 2019
13Commission Regulation (EU) 2018/1480II

 

Regulation (EU) 2019/1966

 

1 December 2019 and 1 May 202
14Delegated Regulation (EU) 2020/217IIIRegulation EU 2021/8509 September 2021
15Delegated Regulation (EU) 2020/1182IVRegulation (EU) 2021/19021 March 2022
17Delegated Regulation (EU) 2021/849VRegulation (EU) 2022/153117 December 2022
18Delegated Regulation (EU) 2022/692VIRegulation (EU) 2023/1490 1 December 2023
21Delegated Regulation (EU) 2024/197VIIAdoption expected by Q2 20251 September 2025
22Delegated Regulation (EU) 2024/2564VIIIUnder preparation1 May 2026